Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income	$ 15,333	$ 7,322
Adjustments to reconcile net income to net cash provided by operations:
Impairments and other non-cash charges	0	2,816
Depreciation and amortization	14,835	15,803
Stock-based compensation expense	3,122	3,298
Provision for deferred income taxes	(2,196)	(916)
Credit loss expense	1,040	464
Gain on sale of assets	(1,049)	(1,649)
Gain on insurance recovery	(874)	0
Amortization of original issue discount and debt issuance costs	260	274
Change in assets and liabilities:
Decrease in receivables	4,369	39,324
(Increase) decrease in inventories	12,158	(3,440)
Increase in other assets	(1,524)	(3,187)
Increase (decrease) in accounts payable	647	(14,453)
Decrease in accrued liabilities and other	(6,590)	(8,808)
Net cash provided by operating activities	39,531	36,848
Cash flows from investing activities:
Capital expenditures	(20,468)	(15,347)
Proceeds from divestitures	0	18,086
Proceeds from sale of property, plant and equipment	2,042	2,304
Proceeds from insurance property claim	1,385	0
Net cash provided by (used in) investing activities	(17,041)	5,043
Cash flows from financing activities:
Borrowings on lines of credit	87,444	149,253
Payments on lines of credit	(101,077)	(167,435)
Purchases of treasury stock	(4,332)	(21,966)
Proceeds from employee stock plans	17	0
Other financing activities	(7,040)	(2,864)
Net cash used in financing activities	(24,988)	(43,012)
Effect of exchange rate changes on cash	(961)	332
Net decrease in cash, cash equivalents, and restricted cash	(3,459)	(789)
Cash, cash equivalents, and restricted cash at beginning of period	38,901	25,061
Cash, cash equivalents, and restricted cash at end of period	$ 35,442	$ 24,272